174 related articles for article (PubMed ID: 16379509)
1. Elevated prolactin levels in male youths treated with risperidone and quetiapine.
Stevens JR; Kymissis PI; Baker AJ
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):893-900. PubMed ID: 16379509
[TBL] [Abstract][Full Text] [Related]
2. The effect of long-term antipsychotic treatment on prolactin.
Staller J
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):317-26. PubMed ID: 16768639
[TBL] [Abstract][Full Text] [Related]
3. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
[TBL] [Abstract][Full Text] [Related]
4. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
Keller R; Mongini F
Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
[TBL] [Abstract][Full Text] [Related]
5. Prolactin levels in young children with pervasive developmental disorders during risperidone treatment.
Masi G; Cosenza A; Mucci M
J Child Adolesc Psychopharmacol; 2001; 11(4):389-94. PubMed ID: 11838821
[TBL] [Abstract][Full Text] [Related]
6. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
[TBL] [Abstract][Full Text] [Related]
7. A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents.
Swadi HS; Craig BJ; Pirwani NZ; Black VC; Buchan JC; Bobier CM
Int Clin Psychopharmacol; 2010 Jan; 25(1):1-6. PubMed ID: 19809337
[TBL] [Abstract][Full Text] [Related]
8. Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
Roke Y; Buitelaar JK; Boot AM; Tenback D; van Harten PN
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):432-9. PubMed ID: 23234586
[TBL] [Abstract][Full Text] [Related]
9. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Fric M; Laux G
Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
[TBL] [Abstract][Full Text] [Related]
11. Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapine.
Kunwar AR; Megna JL
Ann Pharmacother; 2003 Feb; 37(2):206-8. PubMed ID: 12549948
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents.
Saito E; Correll CU; Gallelli K; McMeniman M; Parikh UH; Malhotra AK; Kafantaris V
J Child Adolesc Psychopharmacol; 2004; 14(3):350-8. PubMed ID: 15650492
[TBL] [Abstract][Full Text] [Related]
13. Prolactin elevation with ziprasidone.
Lusskin SI; Cancro R; Chuang L; Jacobson J
Am J Psychiatry; 2004 Oct; 161(10):1925. PubMed ID: 15465997
[No Abstract] [Full Text] [Related]
14. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
Roke Y; van Harten PN; Boot AM; Buitelaar JK
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.
Koch MT; Carlson HE; Kazimi MM; Correll CU
J Am Acad Child Adolesc Psychiatry; 2023 Sep; 62(9):1021-1050. PubMed ID: 36931560
[TBL] [Abstract][Full Text] [Related]
16. Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.
Hellings JA; Zarcone JR; Valdovinos MG; Reese RM; Gaughan E; Schroeder SR
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):885-92. PubMed ID: 16379508
[TBL] [Abstract][Full Text] [Related]
17. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
Chen CK; Huang YS; Ree SC; Hsiao CC
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.
Kelly DL; Conley RR
Psychoneuroendocrinology; 2006 Apr; 31(3):340-6. PubMed ID: 16198059
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
[TBL] [Abstract][Full Text] [Related]
20. Some effects of risperidone and quetiapine on growth parameters and hormone levels in young pigtail macaques.
Sackett G; Unis A; Crouthamel B
J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):489-93. PubMed ID: 21186967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]